CompletedPhase 3NCT02794168

Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury

Studying Moderate and severe traumatic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
veriNOS operations GmbH
Principal Investigator
Erich Schmutzhard, Prof. MD
Medical University Innsbruck
Intervention
VAS203(drug)
Enrollment
224 target
Eligibility
18-60 years · All sexes
Timeline
20162020

Study locations (29)

Collaborators

ICON plc

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02794168 on ClinicalTrials.gov

Other trials for Moderate and severe traumatic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Moderate and severe traumatic brain injury

← Back to all trials